Alekha K. Dash, RPh, PhD

Department

• Pharmacy Sciences

Position

• Professor

Secondary Appointment

• School of Medicine

• MPS 691 - Pharmaceutical Sciences Seminar, 2014-Present
• MPS 692 - Directed Independent Study - MPS Program - 1995-Present
• MPS 693 - Directed Independent Research - MPS Program - 1995-Present
• MPS 799 - Master's Thesis, 1995-Present
• PHA 327 - Pharmaceutics II, 2001-2011

Books

• , 2013, 273-303
• , 2013, 161-180
• , 2013, 153-159
• , 2013, 51-84
• , 148, 177-202

Articles

• , 13, 3226
• , 24, 6
• , 12, 775-788
• , 608, 121-127
• , 54
• , 27(9), 971-983
• , 20
• , 9(12), 849-855
• , 19, 2543-2553
• , 18(7), 2814-2823
• , 18, 2291-2302
• , 17(3), 640-651
• , (9 pages)
• , 16, 98-107
• , 6, 27-39
• , 7, 1863-1876
• , 6, 437-448
• , 6, 1397-1412
• , 11, 392-401
• , 26, 1963-1973
• , 9, 198
• , 26, 333-372
• , 5, 358-366
• , 33, 681-689
• , 9, 486-493
• , 43, 1796-1803
• , 7, 53
• , 93, 1804-1814
• , 276, 83-92
• , 32, 125-132
• , 20, 21-57
• , 29, 939-945
• , 241, 293-299
• , 91, 983-990
• , 91, 708-718
• , 90, 1593-1598
• , 47, 611-615
• , 213, 103-116
• , 27, 379-381
• , 27, 67-113
• , 25, 209-242

Presentations

Research and Scholarship Interests

• Design and Evaluation of Novel Drug Delivery Systems, Preformulation Studies, Solid-State Characterization of Drugs and Dosage Forms, Pharmaceutical Analysis Utilizing the Following Techniques: HPLC, GC, GC-MS, Thermoanalytical methods, IR, Powder X-ray Diffraction and Scanning Electron Microscopy, and Evaluation and Design of Dosage Forms for Nutraceuticals

Grant Funding Received

• Dash, A.K., Development, validation and analysis of creatine and leucin in plasma samples, Phenolics LLC, Omaha, NE
• Dash A.K. Omaha Family Foundation Award matching fund for the purchase of a GPC system
• Dash, A.K., Disodium Phosphocreatine: Evaluation of its Physicochemical Properties and Permeabilitys, Phenolics LLC, Omaha, NE
• Dash, A.K., Evaluation of Leucine Permeability Studies, Phenolics LLC, Omaha, NE
• Dash A.K. Omaha Family Foundation Award for the purchase of ERWEKA–All Purpose R&D Equipment–Model AR 403
• Dash A.K. Robert B. Daugherty Foundation Capital Project Award for the purchase of a LC-MS-MS (API 5500 Q-trap)
• Dash, A.K., Thermal Analysis and Evaluation of Crystal Growth at a Low Temperature on Some Pet Care Products, Sergent’s Pet Care Products Co.
• Dash, A.K. (Co-PI) and Venkatesh Govindarajan (PI), Acquired Resistance to Targeted Therapy in Mucinous Colorectal Cancers. LB595 Grant
• Dash, A.K., Evaluation of Creatine Permeability Studies, Phenolics LLC, Omaha, NE
• Dash, A.K., Evaluation of Various Chewable Tablet Formulations, Fitzpatrick, Cella, Harper & Scinto
• Dash, A.K., Evaluation of Vacuant vs Enemeez, Alliance Labs LLC
• Dash, A.K., Use of Pharmaceutics in the Development of Pet Care Products, Sergent’s Pet Care Products Co.
• Dash, A.K. (CO-PI) and Govindarajan V., PMP: Biologic Foundations for New Treatment Option, National Organization of Rare Disorders (NORD)
• Dash, A.K., President’s Faculty Research Fund, Novel Skin-bound Melanoidins-Sunscreen a Delivery Approach to Melanoma Prevention
• Dash, A.K., LB 692 New Initiatives Research Grant Program, State of Nebraska Cancer & Smoking Grant, Nanome™: A Novel Nanodelivery System for Tumor Targeting
• Dash, A.K., Thermolife International, Creatine Nitrate solubility and stability

• Diffusion Cell, 2020
• US Patent 10,613,011, 2020
• Academic Excellence Award-2019, Association of Pharmacy Professionals (APP), India, 2020
• Liposomal Drug Formulations with Light Illumination-Induced Drug Release, 2020
• US Patent Application No. 15/237,826 - Non-Provisional Application Filed on 8/16/2016. Composition and Method for Preparing Multifunctional Targeting Complexes, Inventors Igor Meerovich, Alekha Dash and D. David Smith., 2016
• Provisional Patent Application (#62397750) filled on 3/14/2016. Diffusion Cells, Inventors Daniel Munt and Alekha Dash., 2016
• USAID Consultant to Armenia, 2013
• Department of Pharmaceutics, Faculty of Pharmacy, Kuwait University, 2012
• Trademark registration (Reg. No. 3,687,057) on “NANOME™”. Registered on Sept 22, 2009., 2009
• Healthway Pharmacy Technology, MD, 2008
• Mucoadhesive Nanoparticles For Cancer Treatment (A. Dash and W. Trickler) Filled on October 26, 2006. Issued US Patent 20100323977., 2007
• Hydroxyapatite Based Drug Delivery Implant for Cancer Treatment; US Patent # 6767550, July 2004., 2004
• Foam-Film System with Antibacterial Properties and Methods for Reducing Bacterial Contamination in Animal Carcasses, Filed on November 15, 2003. International Application #: PCT/US04/038094., 2003